Covid-19 vaccine: Pfizer, J&J entry could still be months away

US pharma biggies Pfizer, Johnson & Johnson and Moderna could be amongst the potential gainers of the government’s decision to fast-track approvals for foreign-produced Covid-19 vaccines. While Johnson & Johnson is keen to enter India and has held preliminary discussions for applying for an emergency approval recently, Pfizer withdrew in February from the race due to regulatory issues.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.